Net Income

The CRDMO giant posted a 16.7% revenue jump in 2025, driven by a massive pipeline expansion and a strategic pivot to next-generation biologics.

RA Capital's major investment extends Karyopharm's runway, but future funding is now directly tied to the outcome of its pivotal endometrial cancer trial.

Israel's kosher food giant rewards shareholders with a hefty dividend, backed by record profits and demonstrating resilience in a volatile global market.

How one brand’s commitment to safer, high-performance nail care earned it a top spot on Fast Company’s Most Innovative Companies list for 2026.

China's travel giant saw profits surge by 22% in 2025, leveraging AI and a focus on lower-tier cities to capture the country's booming mass travel market.

Automotive safety titan Autoliv enters the wearable tech space with an advanced airbag vest, promising to bring car-level protection to motorcyclists.

A medical mission for 750 residents highlights HD Hyundai's strategy to pair massive shipbuilding and defense investments with deep community engagement.

A new platform is launching to connect pharma companies directly with 70+ global regulators, promising to slash approval times and speed patient access.

Global e-bike leader Yadea deepens its Thai ties, showcasing advanced manufacturing and a localized strategy to capture Southeast Asia's booming EV market.

As Virgin Galactic races towards its 2026 commercial launch, it brings in a tech growth expert to navigate the path from cash burn to profitability.

With positive safety data for its novel UC drug, a €530M cash reserve, and a new commercial chief, Abivax is poised for a major market entry.

The homesite developer declared a $0.76 quarterly dividend, showcasing a resilient model that thrives by offering builders an asset-light land strategy.

A new Phase 2 trial is testing an inhaled version of a key IPF drug, aiming to reduce severe side effects and transform treatment for the fatal lung disease.

With a cash runway into 2027, the biotech firm prepares for critical data on its innovative bispecific antibody pipeline for hard-to-treat solid tumors.

Honored as a Top Woman to Watch, Christa Rugova is revolutionizing refrigerated logistics with innovative technology and inspiring a new generation of leaders.

A new study claims combining two cheap inflammation tests saves millions by cutting misdiagnoses, challenging years of cost-cutting medical advice.

A new CEO with a diverse background in aviation and automotive is set to steer the Thompson family's Texas energy and real estate empire into a new era.

A rapid sepsis test is proving its worth, slashing mortality rates and costs across diverse hospitals, offering a new blueprint for emergency care.

A 5-year pilot program will use advanced software to transform D.C.'s rooftop solar and EV chargers into a coordinated force for grid stability.

Amid rising storm damage and insurance demands, one AI startup is expanding nationally with tech that promises to transform how roofs are inspected and repaired.